Proof of Usefulness Report

Grafton Biosciences

Analysis completed on 3/19/2026

-38.5

Proof of Usefulness Score

Lab Mode

The submission contains major red flags and contradictions. While claiming to be a stealth-mode startup, it simultaneously states that 'everyone' and 'most people' have used the product. Claims of $40 million in funding strongly conflict with a reported $2.5 million all-time market cap. The provided information is unverified, logically inconsistent, and highly suspicious.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+25

Audience Reach Impact-20

Technical Innovation+7.5

Evidence Of Traction-50

Market Timing Relevance+10

Functional Completeness-7.5

Subtotal-35

Usefulness Multiplierx1.1

Final Score-38

Project Details

Project URL

graftonbio.com

Description

Grafton Biosciences is a stealth-mode, Bay Area-based biotech startup focused on solving disease through innovations in synthetic biology, machine learning, and manufacturing. With $40 million in funding to-date, we are building next-generation early detection tools and therapeutics to fundamentally extend healthy human lifespans.

Algorithm Insights

Market Position

Early stage requiring focused development

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline